Efficacy of Manual Pressure in Infants
The Effect of Applying Manual Pressure Before Vaccination on Pain and Crying Time in Infants
1 other identifier
interventional
70
1 country
1
Brief Summary
Manual pressure is an effective, easy-to-apply, no preparation, and cost-effective method of reducing pain associated with the injection. This study will be carried out to determine the effect of manual pressure applied to the injection site on the pain level and crying time of the infants before the injection of the Diphtheria-Tetanus-Acellular Pertussis Vaccine (DTaP), Inactivated Polio Vaccine (IPV), and Haemophilus Influenzae Type b Vaccine (Hib) (5-in-1) in 2-month-old infants. The study will be conducted with the randomized controlled experimental method. Before the procedure, manual pressure will be applied to the injection site with the thumb for 10 seconds to the infants in the experimental group. No non-pharmacological method will be used before vaccination to the infants in the control group. Pain scores of infants in the intervention and control groups will be evaluated before, during, and after vaccination. In addition, the total crying times of the babies will be calculated and recorded with a stopwatch.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2021
CompletedFirst Posted
Study publicly available on registry
December 3, 2021
CompletedStudy Start
First participant enrolled
December 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 2, 2022
CompletedJune 15, 2022
November 1, 2021
6 months
November 17, 2021
June 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of Pain
Pain will assess by the healthcare provider who performs the venipuncture procedure with the FLACC (Face, Legs, Activity, Cry, Consolability) Scale. This scale was developed to evaluate the pain of children aged 2 months to 7 years. The child's facial expression, leg movements, activity, crying, and comfortability behaviors are evaluated in relation to pain. These five behaviors are rated with 0, 1, or 2 points. The total score of the scale ranges from 0 to 10, and a high score indicates that the child has more pain. '0' points from the scale indicate no pain, '1-3' points indicate mild pain, '4-6' points indicate moderate pain, and '7-10' points indicate severe pain.
Before vaccine injection, when the vaccine starts to be injected and immediately after the injector was removed.
Secondary Outcomes (1)
Crying time
During vaccine injection and immediately after injection
Study Arms (2)
Experimental Group
EXPERIMENTALBefore the procedure, manual pressure will be applied to the injection site with the thumb for 10 seconds to the infants by the researcher.
Control Group
NO INTERVENTIONNo intervention will perform to reduce pain in the control group.
Interventions
In the experimental group manual pressure will be applied to the injection site with the thumb for 10 seconds to the infants by the researcher before the procedure. Manual pressure reduces pain within the framework of the gate control theory. According to the gate control theory, when pressure is applied to an area, a fiber transmits the feeling of pressure instead of pain and ultimately the pain sensation is alleviated.
Eligibility Criteria
You may qualify if:
- Being a healthy baby born at term
- Being 4 months old
- Having no chronic disease,
- Having no neurological disease.
- Not taking an analgesic drug within 24 hours before vaccination.
You may not qualify if:
- Being an unhealthy baby born at preterm or post-term,
- Being younger or older than 4 months old,
- Having a chronic disease,
- Having a neurological disease,
- Taking an analgesic drug within 24 hours before vaccination.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kumkapi Family Health Center
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, PhD
Study Record Dates
First Submitted
November 17, 2021
First Posted
December 3, 2021
Study Start
December 15, 2021
Primary Completion
June 2, 2022
Study Completion
June 2, 2022
Last Updated
June 15, 2022
Record last verified: 2021-11